telemedicine robot FDA approves first autonomous telemedicine robot for hospitals

The US Food and Drug Administration (FDA) has approved the first autonomous navigation remote presence robot for use in hospitals, paving the way for advances in telemedicine.

The US Food and Drug Administration (FDA) has approved the first autonomous navigation remote presence robot for use in hospitals, paving the way for advances in telemedicine.

 
The RP-VITA, developed by iRobot and InTouch Health, allows remote doctor-to-patient consultation, travelling to and from patients with ease, allowing physicians to interact with more people from anywhere in the world.
 
With an array of sophisticated sensors, the robot can detect obstacles in its environment and safely navigate around them, an essential feature for the busy corridors of hospitals.
 
telemedicine robot FDA approves first autonomous telemedicine robot for hospitals
 
The robot also has integrated electronic health record software, keeping doctors up to date. It can be controlled from an iPad, letting health workers communicate with one another, and with patients, with just a single click.
 
The FDA approval means the robot is clear for use for monitoring of patients during pre-operative, peri-operative and post-surgical settings, including cardiovascular, neurological, prenatal, psychological, and critical care assessments and examinations.
 
“FDA clearance of a robot that can move safely and independently through a fast-paced, chaotic and demanding hospital environment is a significant technological milestone for the robotics and healthcare industries,” said Colin Angle, chairman and CEO of iRobot. “There are very few environments as difficult to manoeuvre as that of a busy ICU or emergency department. Having crossed this technology threshold, the potential for self-navigating robots in other markets, and for new applications, is virtually limitless.”